JAMA Neurology : Impact Factor & More
eISSN: 2168-6157pISSN: 2168-6149
Share this on:
Aims and Scope of JAMA Neurology
JAMA Neurology is a monthly peer-reviewed medical journal published by the American Medical Association. It was established in 1960 as Archives of Neurology and obtained its current name in 2013. The journal publishes research on the nervous system as well as the various mechanisms of neurological disease. The editor-in-chief is S. Andrew Josephson. Less
Key Metrics
CiteScore 
34.1
Eigenfactor
0.01 - 0.05
Impact Factor
>= 25
Scite Index
0.86 5-Year SI
SJR
Q1Neurology (clinical)
SNIP
6.33
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JAMA Neurology
JAMA Neurology Journal Specifications
| Overview | |
| Publisher | AMER MEDICAL ASSOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JAMA Neurology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JAMA Neurology
Multiple Sclerosis Onset Preceding Epstein-Barr Virus Infection
- 3 Aug 2026
- JAMA Neurology
Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis
- 3 Aug 2026
- JAMA Neurology
Automated Speech Analysis to Identify Clinical, Anatomical, and Pathological Variants of Primary Progressive Aphasia
- 3 Aug 2026
- JAMA Neurology
Global and Partial Cataplexy, Geste Antagoniste, and Startle Response in Narcolepsy Type 1
- 3 Aug 2026
- JAMA Neurology
Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy
- 27 Jul 2026
- JAMA Neurology
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis
- 27 Jul 2026
- JAMA Neurology
Multiple Sclerosis Onset Preceding Epstein-Barr Virus Infection
- 3 Aug 2026
- JAMA Neurology
Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis
- 3 Aug 2026
- JAMA Neurology
Automated Speech Analysis to Identify Clinical, Anatomical, and Pathological Variants of Primary Progressive Aphasia
- 3 Aug 2026
- JAMA Neurology
Global and Partial Cataplexy, Geste Antagoniste, and Startle Response in Narcolepsy Type 1
- 3 Aug 2026
- JAMA Neurology
Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy
- 27 Jul 2026
- JAMA Neurology
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis
- 27 Jul 2026
- JAMA Neurology
FAQs on JAMA Neurology
How long has JAMA Neurology been actively publishing? 
What is the publishing frequency of JAMA Neurology?
How many articles did JAMA Neurology publish last year?
What is the eISSN & pISSN for JAMA Neurology?
What is Citescore for JAMA Neurology?
What is SNIP score for JAMA Neurology?
What is the SJR for JAMA Neurology?
Who is the publisher of JAMA Neurology?
